USANA
April 26, 2022
USANA Health Sciences said first-quarter 2022 net sales were 272.9 million dollars, down 11 percent from a year earlier. Diluted earnings per share were 1.15 dollars, versus 1.45 dollars a year earlier. Active customers fell 11 percent to 552,000. Asia Pacific sales were 218.4 million dollars, down 13 percent, while Americas and Europe sales were 54.4 million dollars, down 4 percent.
Chief executive and chairman Kevin Guest said Lunar New Year softness in key Asia Pacific markets and escalating China COVID lockdowns weighed on results. The company revised 2022 guidance to net sales of 1.10 billion to 1.20 billion dollars and diluted earnings per share of 5.00 to 5.70 dollars. It ended the quarter with 238 million dollars in cash after buying back 288,000 shares for 25 million dollars.